Similar articles

• Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?

  Stiles MM, Martin S, Persons RK. Stiles MM, et al. J Fam Pract. 2006 May;55(5):435-6. J Fam Pract. 2006. PMID: 16670040 Review. No abstract available.
• [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].

  Strnad J, Bahro M. Strnad J, et al. Dtsch Med Wochenschr. 2000 Jul 7;125(27):835-9. doi: 10.1055/s-2000-7013. Dtsch Med Wochenschr. 2000. PMID: 10929539 Review. German. No abstract available.
• Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.

  Senin U, Cherubini A, Palumbo B, Mecocci P. Senin U, et al. Funct Neurol. 1997 May-Aug;12(3-4):211-2. Funct Neurol. 1997. PMID: 9218980 No abstract available.
• Galantamine for Alzheimer's disease and mild cognitive impairment.

  Cusi C, Cantisani TA, Celani MG, Incorvaia B, Righetti E, Candelise L; Cochrane Neurological Network. Cusi C, et al. Neuroepidemiology. 2007;28(2):116-7. doi: 10.1159/000101510. Epub 2007 Apr 4. Neuroepidemiology. 2007. PMID: 17409773 No abstract available.
• [Therapy in Alzheimer disease].

  Kovács T. Kovács T. Orv Hetil. 2004 Apr 25;145(17):925-8. Orv Hetil. 2004. PMID: 15170971 Review. Hungarian. No abstract available.